We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Blog

Developing Novel Therapies for the Treatment of Respiratory Diseases
Blog

We recently had the pleasure of speaking with Martin Gosling, Enterprise Therapeutics’ CSO and Professor of Molecular Pharmacology at the University of Sussex. Martin highlights the respiratory diseases Enterprise Therapeutics primarily focus on and the new disease modifying therapies they have in development.

Read More

Enabling Accurate One-step DNA Assembly
Blog

Long sequences of DNA are a key requirement for researchers to be able to develop novel synthetic biomolecules. However, assembling long sequences can prove problematic and slow down the process of gene assembly. GenBrick™ utilizes a novel proprietary technology to enable accurate one-step DNA assembly. We spoke with Cedric Wu, Ph.D., GenScript Sr. Director of R&D to learn more about the capabilities of GenBrick™.

Read More

Using Artificial Intelligence to Identify Bloodborne Bacteria
Blog

Fluid Imaging Technologies and the University of Colorado Boulder have recently entered an exclusive research agreement to determine whether the University’s artificial intelligence software can identify bloodborne bacteria. We spoke with Kent Peterson, CEO, Fluid Imaging Technologies, to learn more about the collaboration, the technologies involved, and how they could impact patients.

Read More

First-of-its-Kind Cyclic IMS Promises Unlimited Experimental Opportunities
Blog

Ion mobility spectrometry (IMS) coupled to mass spectrometry (MS) has witnessed significant growth over the last two decades. To better understand IMS, the benefits this technology provides, and exactly what Waters' new SELECT SERIES CyclicTM IMS offers, we spoke to Emma Marsden-Edwards.

Read More

Building Better Neural Networks
Blog

Given the brain's complexity, it's no surprise that deep neural networks (DNN), computing system based on the brain, are challenging to design and improve. That is a challenge that companies like DarwinAI are meeting head-on. We talked to Sheldon Fernandez, DarwinAI’s CEO, to find out more.

Read More

Targeting Tau Pathology to Slow Alzheimer’s Disease Progression
Blog

To learn more about AC Immune's series of compounds designed to target tau aggregation, we recently spoke with Prof. Andrea Pfeifer, the company's Chief Executive Officer.

Read More

Talking NGS, Liquid Biopsies and Tumor Mutational Burden With Luca Quagliata
Blog

We recently spoke with Luca Quagliata, Ph.D., Global Director of Medical Affairs for Thermo Fisher Scientific. Previously, Quagliata was involved in one of the first teams in Europe to introduce Next Generation Sequencing (NGS) in routine molecular diagnostics. Here, he shares his perspectives on the field, particularly the use of NGS in the analysis of liquid biopsies, the discovery of cancer biomarkers and the potential application of artificial intelligence (AI) in molecular diagnostics.

Read More

Single Cell Analysis – Advantages, Challenges, and Applications
Blog

We recently spoke with Dr Marian Rehak, VP of Research and Development at Sphere Fluidics, to learn more about the importance of single cell analysis. Marian touches on some of the common challenges encountered and highlights some of the key applications.

Read More

Agilent’s Latest Acquisition in the Cell Analysis Space: BioTek Instruments
Blog

Agilent Technologies Inc. recently announced it had signed an agreement to acquire BioTek Instruments, a global leader in life science instrumentation.

Read More

Size Matters: Diffusion Technique Sorts Out Pathological Proteins
Blog

Proteinopathies are diseases that feature misfolded proteins. In the brain, proteinopathies are rife, but research techniques are facing up to the challenge of studying these diseases. We talked to the University of Cambridge’s Tom Scheidt, whose research uses an innovative technique called diffusional sizing to better understand proteins.

Read More